BRIEF-Halozyme Therapeutics Outlook FY Revenue USD 1,385-1,400 Million
Halozyme Therapeutics, Inc. +0.49% Post
Halozyme Therapeutics, Inc. HALO | 67.31 67.31 | +0.49% 0.00% Post |
Feb 17 (Reuters) - Halozyme Therapeutics Outlook FY revenue USD 1,385-1,400 million.
